The UC Melanoma and Skin Cancer Consortium (UCMSCC) applies state-of-the-art research and clinical expertise from all five of UC’s NCI-designated Comprehensive Cancer Centers to disparity in access to clinical trials, and to discovery and development of new treatment options.
Clinical trials and projects
Melanoma and skin cancer clinical trials across the UC System
Upcoming events
Melanoma Research Conference
March 22, 2024, 4 p.m. PT
Speaker: James Lee, MD
Title: Preclinical modeling of strategies to overcome liver metastasis induced immune tolerance
Join the Zoom meeting here.
Funding Opportunities
The UC Melanoma and Skin Cancer Consortium supports projects that encourage collaboration among UC campuses. For additional information, contact Mike Wong.
About us
We envision better patient outcomes and survival achieved through our current and future clinicians and physician scientists’ commitment to breakthrough treatment and access to care – including for Californians most at risk for melanoma and non-melanoma skin cancers.
Leadership
UC Irvine Chao Family Comprehensive Cancer Center
Warren Chow, M.D. (Vice Chair)
Thuy Tran, M.D. (Vice Chair)
UC San Diego Moores Cancer Center
Greg Daniels, M.D., Ph.D. (Vice Chair)
Soo Park, M.D. (Vice Chair)
UCSF Helen Diller Family Comprehensive Cancer Center
Adil Daud, M.D. (Chair)
Max Krummel, Ph.D. (Vice Chair)
Additional Members
UC Davis Comprehensive Cancer Center
Scott Christensen, M.D.
UCLA Jonsson Comprehensive Cancer Center
Bartosz Chmielowski, M.D.
UC San Diego Moores Cancer Center
Brian Hinds, M.D.
Nathan Scott, M.D., M.P.P.
UCSF Helen Diller Family Comprehensive Cancer Center
Jason Chan, M.D.
James Lee, M.D.
Lauren Levine, M.D.
Katy Tsai, M.D.
Working groups
- Education and Outreach
- Translational Medicine
- Research